3,192 Danaher Corporation $DHR Shares Sold by LaFleur & Godfrey LLC

LaFleur & Godfrey LLC cut its stake in shares of Danaher Corporation (NYSE:DHR) by 23.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,268 shares of the conglomerate’s stock after selling 3,192 shares during the quarter. LaFleur & Godfrey LLC’s holdings in Danaher were worth $2,275,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Pinnacle Wealth Planning Services Inc. increased its stake in Danaher by 4.7% in the third quarter. Pinnacle Wealth Planning Services Inc. now owns 3,600 shares of the conglomerate’s stock valued at $797,000 after acquiring an additional 163 shares during the last quarter. North Dakota State Investment Board lifted its stake in Danaher by 3.4% during the third quarter. North Dakota State Investment Board now owns 19,355 shares of the conglomerate’s stock worth $4,288,000 after purchasing an additional 631 shares during the last quarter. North Star Investment Management Corp. boosted its holdings in shares of Danaher by 341.1% in the 3rd quarter. North Star Investment Management Corp. now owns 2,360 shares of the conglomerate’s stock worth $523,000 after purchasing an additional 1,825 shares in the last quarter. Laurel Wealth Advisors LLC bought a new position in shares of Danaher during the 3rd quarter valued at about $214,000. Finally, Sigma Investment Counselors Inc. increased its position in shares of Danaher by 11.5% during the 3rd quarter. Sigma Investment Counselors Inc. now owns 25,589 shares of the conglomerate’s stock valued at $5,669,000 after purchasing an additional 2,642 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 0.7%

Shares of DHR opened at $233.72 on Thursday. The stock has a market capitalization of $164.43 billion, a P/E ratio of 38.25, a PEG ratio of 2.89 and a beta of 0.76. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. The firm has a fifty day simple moving average of $218.10 and a two-hundred day simple moving average of $201.81.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $1.92 by $0.19. The firm had revenue of $6.55 billion during the quarter, compared to the consensus estimate of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The company’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.89 earnings per share. On average, research analysts anticipate that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher’s dividend payout ratio is presently 26.19%.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the company. Royal Bank Of Canada raised their price objective on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a report on Monday, October 5th. Citigroup boosted their price objective on shares of Danaher from $230.00 to $270.00 and gave the stock a “buy” rating in a report on Thursday, October 22nd. Guggenheim upped their price objective on shares of Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a research note on Thursday, October 1st. JPMorgan Chase & Co. upped their price target on shares of Danaher from $250.00 to $270.00 and gave the company an “overweight” rating in a research report on Thursday, October 22nd. Finally, Weiss Ratings upgraded Danaher from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, September 16th. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $242.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.